A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy

Colloids Surf B Biointerfaces. 2023 Feb:222:113069. doi: 10.1016/j.colsurfb.2022.113069. Epub 2022 Dec 5.

Abstract

Re-education of tumor-associated macrophages (TAMs) into M1-like macrophages (Mφ1) has become one of the aims of tumor immunotherapy. Injection of live bacteria has been applied for this purpose; however, an acute innate immune response might be caused in this progress, and therefore a bacteria-based strategy with great security is needed. In this study, the bacterial walls of Staphylococcus aureus were inserted into the bilayer of liposome to construct liposome-based bionic bacteria (Bio-Bac), and doxorubicin (DOX) was encapsulated to form DOX@Bio-Bac. DOX@Bio-Bac re-educated the THP-1-derived TAMs into Mφ1 in vitro, and subsequently inhibited the migration and invasion of CAL27 cells. In a mouse model of hepatocellular carcinoma with lymphatic metastasis, the re-education of TAMs was proved, and an effective inhibition of tumor growth and metastasis in mice was observed. The liposome-based bionic bacteria constructed in this study provide a new strategy for re-education of TAMs, replacing the bacterial therapy reported previously, and a more effective anti-tumor effect can be obtained by combining the chemotherapy drugs with this bionic bacterium.

Keywords: Bionic bacterium; Immunotherapy; Liposome; Staphylococcus aureus; Tumor associated macrophage.

MeSH terms

  • Animals
  • Bacteria
  • Bionics
  • Carcinoma, Hepatocellular* / drug therapy
  • Cell Line, Tumor
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Liposomes
  • Liver Neoplasms* / drug therapy
  • Mice
  • Nanoparticles*
  • Tumor Microenvironment

Substances

  • Liposomes
  • Doxorubicin